Fidelis Partners, LLC
USPTO PatentsView assignee record - 6 granted patents across 6 technology areas, recorded in grant years 2024–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).
The verdict
According to USPTO PatentsView, Fidelis ranks #40,192 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 6 technology areas.
- #40,192
- of 49,997 US assignees by volume
- Top 39%
- by Innovation Score (39.0/100)
- 17.2
- avg claims per patent
USPTO PatentsView assignee plate
Corpus R40192 · US Corporation #40,192 · 6 grants
GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH
- GRANTS-MICRO 6 grants
- LOWER-Q #40,192/49,997
- PHOTO-FINISH Feng HE Ying ZAO Group
- CPC-NARROW A61B · 6 areas
- INNOV-THIN 39.0/100
- CLAIMS-RICH 17.2 claims/avg
- TYPE-USCORP US Corporation
- SPAN-YRS 2024–2025 · 2y
- BOOK-RICH 9/10 fields
Nearest grant-volume peer: Feng HE Ying ZAO Group Co., Ltd. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Fidelis’s 39.0 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Fidelis
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Fidelis Partners · this assignee
Fidelis Partners · this assignee
39 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Fidelis's Innovation Score is 39.0/100 (top 39% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Fidelis?
Each dot is one of Fidelis’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Fidelis’s own 17.2 claims/patent is ABOVE the 13.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Fidelis's grants concentrate
Fidelis Partners, LLC is a focused PatentsView assignee: 6 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). By volume, Fidelis sits between Feng HE Ying ZAO Group Co., Ltd. and Filtran LLC.
Fidelis's three-year grant acceleration
Fidelis Partners, LLC shows 2 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Fidelis's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Feng HE Ying ZAO…
Feng HE Ying ZAO Group Co., Ltd.
6 patents
- Fermob
Fermob
6 patents
- FFF Enterprises
FFF Enterprises, Inc.
6 patents
- Fiac S P A
Fiac S.P.A.
6 patents
- Fidia S P A
Fidia S.P.A.
6 patents
- Fillon
Fillon Technologies
6 patents
- Filtereasy
Filtereasy, LLC
6 patents
- Filtran
Filtran LLC
6 patents
- Fidelis Partners ◀
Fidelis Partners, LLC
6 patents
What this shows Fidelis holds 6 patents at rank #40,162, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Fidelis
By rank, the assignees closest to #40,162 in granted patent volume.
Leaders in A61B (Diagnosis)
Other assignees with the most granted patents in Fidelis's primary technology class.
- Covidien LP 5,709 in class
- Koniniklijke Philips N.V. 3,414 in class
- Olympus Corporation 2,758 in class
- Boston Scientific Scimed, Inc. 2,362 in class
- Cilag GmbH International 2,063 in class
- Intuitive Surgical Operations, Inc. 1,921 in class
- DePuy Synthes Products, Inc. 1,796 in class
- Ethicon, Inc. 1,762 in class
Fidelis's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
39 Top 39% higher than 61% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2024–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2024 | 2 | 33.3% |
| 2025partial year | 4 | 66.7% |
Which technologies does Fidelis Partners, LLC patent most?
Top 6 of 6 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Fidelis Partners, LLC's patent record in context - here's where to go next.
- Fidelis Partners, LLC's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
- Ranked #40,192 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Fidelis Partners, LLC against Feng HE Ying ZAO Group Co., Ltd., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 39.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.